Dark

ANVS
Annovis Bio, Inc.
stock NYSE

Market Open

Nov 18, 2025 10:08:54 AM EST

3.16USD+4.290%(+0.13)2,031,494

3.13Bid 3.16Ask 0.03Spread

Pre-market

Nov 18, 2025 9:27:30 AM EST

3.01USD-0.660%(-0.02)179,017

After-hours

Nov 17, 2025 4:58:30 PM EST

2.98USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

83.35M

Headquarters

Berwyn, Pennsylvania, USA

Industry

Biotechnology

ANVS Stats

Avg. Vol. 10 Day

4,843,415

Avg. Vol. 30 Day

2,564,562

Market Cap

83,351,586

Shares Out.

26,502,889

On/Off Exchange

37%/63%

6 Month Beta

2.56

1 Year Beta

1.57

2 Year Beta

1.79

3 Year Beta

1.46

52 Week Low

1.11

52 Week High

7.52

SMA50

2.16

SMA200

2.19

1 Week

+49.05%

1 Month

+58.84%

3 Month

+16.91%

6 Month

+48.35%

1 Year

-53.89%

2 Year

-48.19%

5 Year

-37.48%

Profile

annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders. the company is also developing anvs405 for protecting the brain after traumatic brain injury and/or stroke; and anvs301, which is in phase i clinical trials to increase cognitive capability in later stages of ad and dementia. annovis bio, inc. was founded in 2008 and is based in berwyn, pennsylvania.

ANVS Stock Summary

Annovis Bio, Inc. (NYSE:ANVS) stock price today is $3.16, and today's volume is 2,031,494. ANVS is up 4.290% today. The 30 day average volume is 2,564,562. ANVS market cap is 83.35M with 26,502,889 shares outstanding.

.dark-mode .vK4PTv{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .vK4PTv{ color: #333333; background-color: white; border: 2px solid #333333; }ANVSAnnovis Bio, Inc.stock NYSE

ANVS Stock Summary

ANVS
Annovis Bio, Inc.
stock NYSE